chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Trigeminal Neuralgia; Nausea; Chills; Body aches; Lightheadedness; Trigeminal nerve disorder; This is a spontaneous report from a contactable nurse (patient). A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot: EL1284/expiration date not provided) via intramuscular route of administration, in left arm, on 19Jan2021 (at the age of 63 years old) as a single dose for COVID-19 IMMUNIZATION. The patient was not pregnant at the time of vaccination. The patient medical history was not reported. Concomitant medication included losartan, amlodipine, metoprolol, esomeprazole magnesium (NEXIUM [ESOMEPRAZOLE MAGNESIUM]). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number: EL0140/expiration date not provided) on 29Dec2020 (at the age of 63 years old) as a single dose in the left arm for COVID-19 immunization. On 20Jan2021, the patient experienced nausea, chills, body aches, lightheadedness, trigeminal nerve disorder. On 22Jan2021, the patient was diagnosed with trigeminal neuralgia. The events resulted in a physician office visit and Emergency Room visit. The seriousness criteria was disabling/incapacitating. The facility where the most recent COVID-19 vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been not been tested for COVID-19. Treatment received for the events included steroids, anti-convulsant and pain relievers. The outcome of the events was not recovered.  Follow-up (08Feb2021): New information from a contactable nurse (patient) includes: new event (trigeminal neuralgia), event details, seriousness criteria, treatment received and events outcome.; Sender's Comments: Based on the plausible temporal association and considering lacking alternative explanations, the Company cannot completely exclude the possible causality between the reported events, nausea, chills, body aches, lightheadedness, trigeminal nerve disorder, Trigeminal Neuralgia and the administration of the COVID-19 vaccine, BNT162B2.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.
Mild headache and severe tinnitus in the right ear after waking the morning after the exam making it difficult to concentrate on work or enjoy normal daily activities.
Right supraclavicular lymphadenopathy; This is a spontaneous report from a non-contactable physician (patient). A 26-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on the right arm on 17Dec2020 07:15 at a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient was not pregnant. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient experienced right supraclavicular lymphadenopathy on 23Dec2020 18:00. No treatment was received for the adverse event. Outcome of the event was not recovered. The event was considered non-serious.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
A shingle scab at injection site, an another one nearby.  Muscle pain, tiredness, weakness, achiness.
4 days of flu-like symptoms (feverish, chills, sweats, body aches all over), very stiff arm & limited motion of arm, severe headache
Grand Mal Seizure at 5:00 AM requiring 911 call, ambulance to ER, CT scan (clear), and release.  Second grand mal seizure at 11:00 AM requiring another 911 call, ambulance to ER, overnight stay including IV with dilantin. Follow up visits with neurologist ongoing.
First two days after second shot was very fatigued, achy and feverish. Woke up on Tuesday morning, 3 Days after second shot left eye lid was swollen  and eye burned badly. Went to Ophthalmologist 3 days later and diagnosed with bleeding retina and inflamed eyeball and irritated upper eyelid with no foreign object in eye. . After 10 days of steroid drops symptoms were the same. Saw ophthalmologist again on 5/17  same issue with no obvious reason as to why My eye is inflamed, gave me stronger drops to use for 10 days. If not better in 10 days I will follow up with a cornea specialist.  I have never had an eye issue until my COVID vaccine.
Dry, non-productive cough has grown from occassional to persisitent/daily within one month (date this form was submitted)
Patient developed asthma after the shot (known asthmatic, no recent wheezing) and required 2 albuterol treatments to clear. Patient then took a nap, which he does not normally do.
My ears started ringing after I got my vaccine.  I don't have any hearing loss.  It hasn't gotten any better.  I found out about VAERS on the Radio.  Please research this.
Urticaria (full body). Still going on as of today. Has taken daily OTC Benadryl - switched to daily Zyrtec.
Feeling tired redness and swelling at site some pain at site, chills headache feeling need to lie down...
Itching, red swollen lines all over my body and face. Diagnosed with urticaria dermatography. I take antihistamines. Still itchy and with dermatography. The itchiness though is better.
pt recv vax 21JUN95 & 5JUL95 pt c/o h/a & began low grade t99-100; 7JUL95 broke out in rash on 7JUL75 temp of 101-103; vomiting on 10JUL95;
Patient developed unilateral facial paresthesia, only in V2 nerve distribution on the left, waxing and waning starting 1 week after receiving the vaccine and persisting through 1/25.  Presented to the ED due to concern over TIA of other neurologic issue. No trauma. No other neurologic complaints whatsoever. Other than decreased sensation to light touch in above area, normal exam including normal neuro exam.
With in 5 mins. of taking pm meds(10pm) ...the top of my tongue went numb and then I started feeling my lips swell   It lasted for about 3 hours but didn't get any worse so didn't call doctor or go to hospital.
Within 1-2 minutes after receiving influenza vaccination, client felt dizzy, weak, felt like going to pass out. Diaphretic and pale. BP taken; pulse.
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    No concomitant medicine were reported. This case was for 13 out of 190 patients reported. No treatment medicine was reported.   This case was linked to MODERNATX, INC.-MOD-2023-704335 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2023-704335:MASTER  CASE
Pt stated she had red spots develop on Rt leg and below knee and on both feet. She states these look like blood spots which were large. No reaction at vaccine administration site. She did not seek medical care because she was between insurers. She had moved. Spots went away in 4-5 days. These areas were itchy per her report. No fever. No associated DIB or SOB. No oral or facial swelling reported by client. No HA or neck pain. Pt. states she has been feeling well. Expressed  to client the importance of seeking medical care with complications following a vaccine. Client verbalized understanding. Advised not to take Meningitis vaccine in the future.
Intense chills, followed  by  nausea, sweats and fever of 103 . Symptoms lasted for 4-5 days.
Within 12 hours -- extreme pain in fingernails and toenails; after 18 hours, overall fatigue, extreme muscle pain, low grade fever of 100 degrees. Need to sleep Lasted only that one day. Two weeks later, welts breaking out on left side of body - thought it was poison ivy, but appeared different. Next day had extreme diarrhea, vomiting for 12 hours. Extreme weakness. Then for one day I was okay other than weakness; 2nd day diarrhea and vomiting returned with extreme weakness.  After about 8 hours, the previous welts spread to all heat spots on my body, both sides, lymph nodes appeared to swell underarm. Itching over entire body to such an extent it was "driving me crazy" --  I took 2 Benadryl with no impact; then took 2 Prednisone 5 mg, then forced myself to ignore itching while sitting in my recliner the rest of the night.  Fell asleep about 2 hours later. When I awoke after 4 hours, the itching and welts were gone.  Within another 6 hours I was able to eat regular diet with no nausea or other side effects. At first, I thought this was diverticulitis because I had eaten popcorn -- but the worst diverticulitis has ever done to me is mild diarrhea and occasional nausea.  Never any of these other issues.
Client reported pressure on her chest and shortness of breath to EMT. RN responded. At 4:50PM the client reported feeling nausea and pressure on her chest. Vitals obtained at 4:51PM were as follows: BP 146/86, HR 79, O2 99%. At 4:52PM the client was provided juice and stated she still felt pressure on her chest. The client began drinking the juice. The client stated she last ate at 8:00 AM. The client reported a history of gastritis. Vitals obtained at 5:00PM were as follows: BP 146/90, HR 85, O2 98%. The client stated the pressure on her chest was improving and denied any current nausea. The client declined an warmness on her chest. The client denied any allergies or current medications. Vitals obtained at 5:10PM were as follows: BP 130/86, HR 80, O2 99%. The client reported less pressure on her chest, denied any shortness of breath, chest pain. Client ate two crackers, finished the juice, and began drinking water provided by staff. The client reported that she experienced body aches, a headache, and fever the day after she received her second COVID vaccine Moderna. The client stated those symptoms lasted one day and improved with taking Tylenol. Vitals obtained at 5:20PM were as follows: BP 136/84, HR 72, O2 99%. The client stated the pressure was almost gone, denied any nausea, chest pain, or warmness. RN educated the client regarding s/s of anaphylaxis and when to seek EMS, the client voiced understanding of this education. The client ambulated out of the vaccination site at 5:24PM unassisted with a steady gait.
This spontaneous case, initially received on 11-Oct-2018, reported by other healthcare professional (nurse) concerns a 54-year-old adult, female patient. The patient's historical vaccine included influenza vaccine (for 25 years). The patient had no historical conditions. On 11-Oct-2018, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 252659 and expiry date: 31-May-2019]. On the same day, after vaccination, the patient experienced a metallic taste in her mouth. The patient was advised to go to the emergency room (ER) if symptoms worsened. The event did not require hospitalization. The patient did not take any treatment measures associated with the event. The patient was already fine in the afternoon of the day (recovered). It was reported that, the patient has had flu shots for 25 years and this had never happened before. The reporter assessed this case as non-serious. Follow-up received from other health professional (nurse) on 09-Nov-2018: The outcome of the event was changed from 'not reported' to 'recovered' in the event tab. the narrative was amended accordingly.
Swelling and itching- Right deltoid (swelling). (Itching)- chest. Right arm, head.
Patient informed me that 24 hours after he received his vaccination he was transported and admitted to the hospital. He was running a 104 degree fever and was suffering from a very erratic  heath rhythm. It took them a significant amount of time to get his heart rhythm under control and or him to be discharged.
After 2nd shot, I had fever of 101 degrees, body aches, headache, nausea for 36 hours after receiving the shot.
This spontaneous report as received from a pharmacist refers to a 59 years old female patient with blood pressure abnormal. The patient's medical history included shingles. The patient was vaccinated with 0.65 ml ZOSTAVAX (subcutaneous in the right arm, Lot# and duration were unspecified) on 18-JUL-2012. Secondary suspect therapies included PNEUMOVAX23 (subcutaneous in the left arm, 0.5ml, Lot# and duration were unspecified) on 18-JUL-2012. Concomitant medications included: DTAP, unspecified pressure medication and other medications(specific names are unknown). It was reported that the patient received ZOSTAVAX in the right arm at the physician's office and experienced a rash at the injection site that was the size of a hand and it was really red and inflamed. It also reported that the patient had an outbreak if shingles 1 and 1/2 years ago in the brain. The patient had sought medical attention via pharmacy visit. No lab diagnostics studies performed. No treatment was given for the AE. The outcome was reported as recovering/resolving. Additional information has been requested.
Symptoms:  facial and chest rash, itching, chest tightness, tachypnea Treatment:  Pepcid, Benadryl, Solumedrol Outcome:  Discharged home
pt exp fatigue, sleepiness & fever 2 days p/vax;on 6JUL97 pt exp elevated liver enzymes;lab values drawn on 29JUL97 confirmed pre results;sx are currently unresolved;pt thyroid level dropping grad over time;poss autoimmune mechanism;
Normal effects but disappeared within a week.  Lymph nodes under my left collar bone are still extremely swollen and painful after 7 months.  I have been extremely tired since this shot as well.
The patient lost his voice, has a tickle in his throat, his neck feels tight, has a headache, generalized flushing, excessive coughing, and burning in the throat and the eyes.
Case number PHEH2016US028413, is an initial spontaneous report received from a consumer on 26 Oct 2016. This report refers to a 63-year-old male patient. Medical history and concomitant medication was not reported. The patient was vaccinated with one single dose FLUVIRIN MDV (batch number: 1619301, expiry date: Apr 2017) at a dose of 05 ml intramuscular on 25 Oct 2016. FLUVIRIN reached to 77 F for 4 days was administered. No adverse event was reported following this medication error.
Information has been received from a physician concerning an 18 year old female patient who on 07-JUL-2009 was vaccinated with the first dose of GARDASIL (Lot number 658271/0558X). On 07-JUL-2009 the patient experienced a headache 2 hours after vaccination with nausea and vomiting. The patient also experienced tingling numbness in the arm where she had the injection. The patient reported these symptoms when she returned in September to receive the second dose of GARDASIL. The physician's office decided to not administer the second dose of GARDASIL at this time. Additional information has been requested.
Per documentation, patient received 12+ Covid 19 vaccine on 12/06/2021, she should have received the 5-11 year old vaccine. This information was shared with parents on 12/27 when she was taken to receive her second doze of the vaccine.
I20.0 UNSTABLE ANGINA 7/13/2021 CHEST PAIN I21.4 ACUTE NON ST ELEVATION MI 7/13/2021 CHEST PAIN I21.9 ACUTE MI 5/26/2021 CHEST PAIN J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/18/2021 CHEST PAIN I20.0 UNSTABLE ANGINA 7/13/2021 DM 2 W HYPERGLYCEMIA I21.4 ACUTE NON ST ELEVATION MI 7/13/2021 DM 2 W HYPERGLYCEMIA I21.9 ACUTE MI 5/26/2021 DM 2 W HYPERGLYCEMIA J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/18/2021 DM 2 W HYPERGLYCEMIA I20.0 UNSTABLE ANGINA 7/13/2021 ATHEROSCLEROSIS OF AORTA I21.4 ACUTE NON ST ELEVATION MI 7/13/2021 ATHEROSCLEROSIS OF AORTA I21.9 ACUTE MI 5/26/2021 ATHEROSCLEROSIS OF AORTA J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/18/2021 ATHEROSCLEROSIS OF AORTA I20.0 UNSTABLE ANGINA 7/13/2021 ACUTE NON ST ELEVATION MI I21.4 ACUTE NON ST ELEVATION MI 7/13/2021 ACUTE NON ST ELEVATION MI I21.9 ACUTE MI 5/26/2021 ACUTE NON ST ELEVATION MI J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/18/2021 ACUTE NON ST ELEVATION MI
Face swells up; Turns really red and itching; Face swells up and turns really red and itching; Really sick the day after she got her second dose; This is a spontaneous report from a contactable consumer (patients mother). A 14-years-old female patient received bnt162b2 (Pfizer covid vaccine, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 12Jun2021 (at the age of 14-years-old) as dose 2, single for COVID-19 immunisation. Medical history included asthma. There were no concomitant medications. The patient previously took BNT162B2 as first dose on 05May2021 or 06May2021(NDC, Expiration Date, Lot: Unknown) administered in left upper arm. On an unspecified date, the patient experienced face swells up, turns really red and itching, face swells up and turns really red and itching, really sick the day after she got her second dose. Patients mother stated she had to take the patient to the emergency room first time this happened, this was already the third time it was happening again and stated the patients face was swelled up and turned really red and itching. Patient mother added it looked like an allergic reaction, but she thought it was not an actual allergic reaction from what she read, she guessed it was her body trying to fight off this and the patient was really sick the day after she received her second dose and thought it was just going to end there with that, as she seemed to be ok for a week or two, and now yesterday and the patients mother gave another Benadryl, because the patient said, the same thing was happening to her face. Patients mother stated that she was calling to report about her daughter has been going though since she had been vaccinated, the patient having adverse reactions and confirms the product was the COVID vaccine and stated she had only a few minutes to go through the report, she was at work, when queried by agent. Therapeutic measures were taken as a result of face swells up, turns really red and itching, face swells up and turns really red and itching. The outcome of the events was unknown.  Information about batch/lot number has been requested.
EYE PAIN; HEADACHE; FLU LIKE SYMPTOMS; ABDOMINAL PAIN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included pollen allergy, and penicillin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced flu like symptoms. On 12-APR-2021, the subject experienced abdominal pain. On 13-APR-2021, the subject experienced headache. On 17-APR-2021, the subject experienced eye pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms, and headache on APR-2021, had not recovered from eye pain, and the outcome of abdominal pain was not reported. This report was non-serious.
Case number PHEH2015US019567 is an initial spontaneous report from a health care professional received on 30 Sep 2015. This report refers to a 47 year old female patient. Historical condition and concomitant medication were not reported. The patient was vaccinated with FLUCELVAX (batch number: 173539) intramuscularly at a dose of 0.5 ml on 23 Sep 2015. It was reported that FLUCELVAX was kept at room temperature for 24 hours before administering the patient. No adverse event was reported following this maladministration (incorrect storage of drug).
Adverse Event NOS; A spontaneous report was received from a consumer concerning a female patient of unknown age received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events possible side effect.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 5 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) possible side effect.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), possible side effect was unknown.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Had shot on 2/17 and presented on 2/22 with significant red, 6cm rash on opposite arm -  he had no prior history of eczema or skin condition.   Symptoms resolved with topical steroid, but recurred again 3/9
Mom called the afternoon of 07/12/2005 24 hours after vaccination.  Had reddened area on right thigh injection area, some bruising, swollen, hard spot, low grade temperature.  No temperature at office.  Told Mom warm baths and advil.
Evening of 1/25/2021 she experienced a sore arm and toss and turned through out hours of sleep. Reports significant s/sx onset this morning arounf 0100, 1/26/2021 to include chest tightness with a sharp pain when inhaling, all over body aches, chills, fatigue and sore arm. Employee states about 1 hr. post vaccination she tasted blood in her mouth and noticed when she . States supervisor referred to OH to be evaluated. Employee also reports hx. of COVID illness with a positive result on 12/27/2021. States onset of s/sx was on 12/26/2021. Patient reported to employee health clinic to report adverse event. On, 1/27/2021 patient was seen by her PCP for evaluation.
Headache, Myalgia, Arthraliga, Fever, Chills, Shakes, accessive sweating and hypersensitivity on skin Narrative:
4 days after the shot, I experienced chest pain, heart beating really fast, body feeling heavy, feeling very hot and almost passing out for about 5 minutes. This occurred while I was bowling. I had to sit down but after a few minutes, and drinking a little water, I was able to get up and keep bowling and I felt fine. I didn?t seek treatment.
Patient is 16 years old and Moderna vaccine is for individuals 18 years and older.
Patient experience redness, rash, warm to touch at site of inject in approximately 30 mins after injection. Pt then began to develop a rash.